NCT04459416: Phase 3: Managing Pain and Symptom Burden Caused by Chemotherapy in Myeloma or Lymphoma
Updated: Feb 21
OPTIMAL-HiChemo
NCT04459416: Phase 3: Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
NCT04459416: Phase 3: Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
The purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone, in reducing opioid use by relieving pain. Researchers also want to find out more about the effects of acupuncture treatments on other symptoms caused by cancer treatments and quality of life.
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Patient-Centered Outcomes Research Institute
Hackensack Meridian Health
ClinicalTrials.gov Identifier: NCT04459416
Official Title: Opioid-Sparing Pain Treatment In Myeloma And Lymphoma Patients Undergoing High-Dose Chemotherapy (OPTIMAL-HiChemo): Randomized Controlled Trial
First Posted : July 7, 2020
Click here for details on ClinicalTrials.gov
Other: Acupuncture
Drug: opioid
Other: Assessments
- New York: Memorial Sloan-Kettering Cancer Center New York
Location
United States, New York
United States, Washington